Patenting motives of pharmaceutical firms: a perspective on changing role of patents and firms' strategy in business
by Vinita Krishna; Sudhir K. Jain
International Journal of Intellectual Property Management (IJIPM), Vol. 11, No. 1, 2021

Abstract: Strategic patenting in the last decades has been studied extensively to reflect on the trends in patenting motives of firms though mostly for large firms and from developed countries. Studies point to the numerous emerging roles of patents. How firms apply their patenting strategy, is still a fragmented area as major variation across sectors exists. Small- and medium-sized firms, rarely studied in detail have been taken up for study by exploring the pharmaceutical sector where patents are integral to success in business. A survey cum secondary data-based study generates insights on firms' ranking of patenting motives and the impact of firms' characteristics on these motives. Protection of invention is reaffirmed as the primary motive, though licensing motive has slipped in rank. Further, inter-firm differences through regressions show that the number of granted patents and firm age positively and significantly impact firm's patenting motives but firm size has no impact.

Online publication date: Mon, 01-Mar-2021

The full text of this article is only available to individual subscribers or to users at subscribing institutions.

Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.

Pay per view:
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.

Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Intellectual Property Management (IJIPM):
Login with your Inderscience username and password:

    Username:        Password:         

Forgotten your password?

Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.

If you still need assistance, please email